EdgarLookup

Baranick Brian

Insider transactions at 1 company

This page shows all SEC Form 4 filings attributed to Baranick Brian. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

EXAS
Company Title Type Shares Price Value Date
EXAS EVP, GM, Precision Oncology Option Exercise 3,955 — — Dec 23, 2025
EXAS EVP, GM, Precision Oncology Sale 2,858 $70.08 $200,289 Nov 4, 2025
EXAS EVP, GM, Precision Oncology Tax Withholding 2,717 $46.83 $127,237 Aug 5, 2025
EXAS EVP, GM, Precision Oncology Tax Withholding 2,513 $47.82 $120,172 Feb 28, 2025
EXAS EVP, GM, Precision Oncology Tax Withholding 2,008 $51.28 $102,970 Feb 25, 2025
EXAS EVP, GM, Precision Oncology Tax Withholding 968 $49.63 $48,042 Feb 19, 2025
EXAS EVP, GM, Precision Oncology Sale 929 $70.00 $65,030 Oct 8, 2024
EXAS EVP, GM, Precision Oncology Sale 929 $70.00 $65,030 Sep 18, 2024
EXAS EVP, GM, Precision Oncology Tax Withholding 1,375 $55.77 $76,684 Aug 5, 2024
EXAS EVP, GM., Precision Oncology Sale 110 $60.15 $6,617 Apr 30, 2024
EXAS EVP, GM., Precision Oncology Sale 924 $79.43 $73,393 Apr 2, 2024
EXAS Gen. Mgr., Precision Oncology Option Exercise 4,724 — — Mar 1, 2024
EXAS Gen. Mgr., Precision Oncology Sale 2,027 $56.89 $115,316 Feb 26, 2024
EXAS Gen. Mgr., Precision Oncology Option Exercise 1,729 — — Feb 21, 2024
EXAS Gen. Mgr., Precision Oncology Sale 1,093 $59.78 $65,340 Feb 21, 2024
EXAS Gen. Mgr., Precision Oncology Sale 879 $73.50 $64,607 Jan 2, 2024
EXAS Gen. Mgr., Precision Oncology Sale 1,350 $85.04 $114,804 Aug 4, 2023
EXAS Gen. Mgr., Precision Oncology Option Exercise 3,954 — — Feb 28, 2023
EXAS Gen. Mgr., Precision Oncology Option Exercise 1,729 — — Feb 22, 2023
EXAS Gen. Mgr., Precision Oncology Sale 984 $47.12 $46,366 Aug 4, 2022